Virtual Meeting to be held on April 3 hosted by Craig-Hallum. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

We recently compiled a list of the 10 Best Emerging Technology Stocks to Buy Now. In this article, we are going to take a look at where GeneDx Holdings Corp. (NASDAQ:WGS) stands against the other ...

We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that, ...

GeneDx Price Performance NASDAQ:WGS opened at $104.39 on Monday. The firm has a market capitalization of $2.93 billion, a price-to-earnings ratio of -53.26 and a beta of 1.91. GeneDx Holdings Corp ...

GeneDx recognized for its innovative approach to accelerating genetic diagnosis and transforming the future of healthcare by ending the diagnostic odyssey “Our list of the Most Innovative ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision ...

GeneDx Recognizes Cerebral Palsy Awareness Month with Commitment to Improve Access to Testing GAITHERSBURG, Md.--(BUSINESS WIRE)-- GeneDx (Nasdaq: WGS), a leader in delivering improved health ...

In this article, we are going to take a look at where GeneDx Holdings Corp. (NASDAQ:WGS) stands against other high growth low debt stocks to invest in now. The global financial markets are ...

GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that, effective as of March 15, 2025, the compensation committee of GeneDx’s board ...